Abstract
Cellular senescence is generally defined as an irreversible state of G1 cell cycle arrest in which cells are refractory to growth factor stimulation. Cellular senescence can be induced through several different mechanisms. Primary mammalian cells display a finite life span, suggesting a mechanism that counts cell divisions. Those cells initially proliferate but eventually enter a state of permanent growth arrest, called replicative senescence. Erosion of telomeric DNA has emerged as a key factor in replicative senescence, which is antagonized during cell immortalization. Nevertheless, besides telomere shortening, there are other mechanisms inducing a growth arrest similar to the replicative senescencent phenotype. Oncogenic or mitogenic signals as well as DNA damage can induce such a phenotype of cellular senescence. All forms of cellular senescence share common signaling pathways and morphological features. Thereby, p53 seems to be essential for the senescence response. Many of these senescence inducing mechanisms can be experimentally recapitulated by the introduction of defined genetic elements. Replicative senescence due to telomere shortening can, for example, be induced by a dominant negative version of telomerase, premature senescence by the overexpression of oncogenic ras, or p16.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hayflick, L. and Moorhead, P. S. (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585–621.
Linskens, M., Harley, C. B., West, M. D., Campisi, J., and Hayflick, L. (1995) Replicative senescence and cell death. Science 267, 17.
Campisi, J. (2000) Cancer, aging and cellular senescence. In Vivo 14, 183–188.
McClintock, B. (1941) The stability of broken ends of chromosomes in Zea mays. Genetics 26, 234–282.
Blackburn, E. H. and Chiou, S. S. (1981) Non-nucleosomal packaging of a tandemly repeated DNA sequence at termini of extrachromosomal DNA coding for rRNA in Tetrahymena. Proc Natl Acad Sci USA 78, 2263–2267.
Harley, C. B., Futcher, A. B., and Greider, W. (1990) Telomeres shorten during aging of human fibroblasts. Nature 345, 458–460.
Levy, M. Z., Allsopp, R. C., Futcher, A. B., Greider, C. W., and Harley, C. B. (1992) Telomere end-replication problem and cell aging. J. Mol. Biol. 225, 951–960.
Bodnar, A. G., Ouellette, M., Frolkis, M., et al. (1998) Extension of life span by introduction of telomerase into normal human cells. Science 279, 349–352.
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W. (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602.
Zhu, J., Woods, D., McMahon, M., and Bishop, J. M. (1998) Senescence of human fibroblasts induced by oncogenic raf. Genes Dev. 12, 2997–3007.
Lin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., and Lowe, S. W. (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12, 3008–3019.
Dimri, G. P., Itahana, K., Acosta, M., and Campisi, J. (2000) Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14/ARF tumor suppressor. Mol. Cell. Biol. 20, 273–285.
McConnell, B. B., Starborg, M., Brookes, S., and Peters, G. (1998) Inhibitors of cyclindependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol. 8, 351.
Ferbeyre, G., de Stanchina, E., Querido, E., Baptiste, N., Prives, C., and Lowe, S. W. (2000) PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14, 2015–2027.
Sherr, J. (1998) Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984–2991.
Dirac, A. M. and Bernards R. (2003) Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53. J. Biol. Chem. 278(14), 11,731–11,734.
Harada, H., Nakagawa, H., Oyama, K., et al. (2003) Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol. Cancer Res. 1(10), 729–738.
Linskens, M. H. K., Feng, J., Andrews, W. H., et al. (1995) Cataloging altered gene expression in young and senescent cells using enhanced differential display. Nucleic Acids Res. 23, 3244–3251.
Sherwood, S. W., Rush, D., Ellsworth, J. L., and Schimke, R. T. (1988) Defining cellular senescence in IMR-90 cells: a flow cytometric analysis. Proc. Natl. Acad. Sci. USA 85, 9086–9090.
Shelton, D. N., Chang, E., Whittier, P. S., Choi, D., and Funk, W. D. (1999) Microarray analysis of replicative senescence. Curr. Biol. 9, 939–945.
Dimri, G. P., Lee, X., Basile, G., et al. (1995) A novel biomarker identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363–9367.
Goldstein, S. (1990) Replicative senescence: the human fibroblast comes of age. Science 249, 1129–1133.
Rheinwald J. G. and Green H. (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6(3), 331–343.
Lindberg, K. and Rheinwald, J. G. (1990) Three distinct keratinocyte subtypes identified in human oral epithelium by their patterns of keratin expression in culture and in xenografts. Differentiation 45, 230–241.
Rheinwald, J. G., Hahn, W. C., Ramsey, M. R., et al. (2002) A two-stage, p16(INK4A)-and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol. Cell Biol. 22, 5157–5172.
Andl, D., Mizushima, T., Nakagawa, H., et al. (2003) Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J. Biol. Chem. 278, 1824–1830.
Stampfer, M. R. (1985) Isolation and growth of human mammary epithelial cells. J. Tissue Culture Methods 9, 107–115.
Foster, S. A. and Galloway, D. A. (1996) Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. Oncogene 12(8), 1773–1779.
Morgenstern, J. P. and Land, H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587–3596.
Hahn, W. C., Stewart, S. A., Brooks, M. W., et al. (1999) Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5, 1164–1170.
Mitra, J., Dai, C. Y., Somasundaram, K., et al. (1999) Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor Mol. Cell Biol. 19(5), 3916–3928.
Miyoshi, H., Blomer, U., Takahashi, M., Gage, F. H., and Verma, I. M. (1998) Development of a self-inactivating lentivirus vector. J. Virol. 72, 8150–8157
Kim, N. W. and Wu, F. (1997) Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25, 2595–2597.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Nakagawa, H., Opitz, O.G. (2007). Inducing Cellular Senescence Using Defined Genetic Elements. In: Tollefsbol, T.O. (eds) Biological Aging. Methods in Molecular Biology™, vol 371. Humana Press. https://doi.org/10.1007/978-1-59745-361-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-59745-361-5_13
Publisher Name: Humana Press
Print ISBN: 978-1-58829-658-0
Online ISBN: 978-1-59745-361-5
eBook Packages: Springer Protocols